Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study.
Xie M, Vuko M, Rodriguez-Canales J, Zimmermann J, Schick M, O'Brien C, Paz-Ares L, Goldman JW, Garassino MC, Gay CM, Heymach JV, Jiang H, Barrett JC, Stewart RA, Lai Z, Byers LA, Rudin CM, Shrestha Y.
Xie M, et al. Among authors: zimmermann j.
Mol Cancer. 2024 May 30;23(1):115. doi: 10.1186/s12943-024-02014-x.
Mol Cancer. 2024.
PMID: 38811992
Free PMC article.
Clinical Trial.